Page last updated: 2024-11-03

propafenone and Angina at Rest

propafenone has been researched along with Angina at Rest in 2 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Câmpeanu, A1
Rădoi, M1
Serban-Pârâu, G1
Pleşca, O1
Nuţă, M1
Teodorescu, V1
Titirigă, M1
Dobrotvorskaia, TE1
Koroleva, ON1
Gordina, OV1
Marakanova, AV1

Trials

1 trial available for propafenone and Angina at Rest

ArticleYear
[Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Klinicheskaia meditsina, 1996, Volume: 74, Issue:3

    Topics: Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Di

1996

Other Studies

1 other study available for propafenone and Angina at Rest

ArticleYear
[The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
    Medicina interna (Bucharest, Romania : 1991), 1993, Volume: 45, Issue:1-2

    Topics: Angina, Unstable; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Dr

1993